SUBSCRIBE
SUBSCRIBE
News   Deals

Iroko Pharmaceuticals Divests Antibiotic Product in Canada

May 16, 2011 | 
1 min read

PHILADELPHIA--(BUSINESS WIRE)--Iroko Pharmaceuticals announced today the sale of its oral antibiotic product, Vancocin® (vancomycin hydrochloride), to Merus Labs International Inc., Vancouver, Canada.

Mergers & acquisitions
MORE ON THIS TOPIC
Creative background
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
February 28, 2025
 · 
2 min read
 · 
Annalee Armstrong
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
February 27, 2025
 · 
1 min read
 · 
Lori Ellis
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Editorial
The BioSpace Book Club Investigates the Biggest Deals of All Time
February 26, 2025
 · 
3 min read
 · 
Annalee Armstrong
Health saving account, HSA, financial plan saving for medical expense or medicare cost and benefits concept, doctor with stethoscope standing with huge pink piggy bank or coin bank with medical sign.
GLP-1
As Money Pours Into Weight Loss Drugs, Physicians Prioritize Efficacy, Access
February 26, 2025
 · 
5 min read
 · 
Annalee Armstrong